{"entity":{"type":"insider","cik":"0001264824","url":"/insider/0001264824","json_url":"/insider/0001264824.json","name":"MPM ASSET MANAGEMENT INVESTORS 2001 LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":7,"first":"2004-06-02","last":"2010-06-29","span_basis":"filed_date"},"name_variants":[{"name":"MPM ASSET MANAGEMENT INVESTORS 2001 LLC","source":"filing","n_filings":7,"first_seen":"2004-06-02","last_seen":"2010-06-29"}],"transactions":[{"id":7271404,"accession":"0001209191-10-035959","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-035959","line_url":"/filing/0001209191-10-035959#line-2","is_derivative":false,"issuer_cik":"0001097136","issuer_name":"SENORX INC","issuer_ticker":"SENO","issuer_name_source":null,"issuer_url":"/issuer/0001097136","owner_cik":null,"owner_name":"MPM ASSET MANAGEMENT INVESTORS 2001 LLC; MPM BIOVENTURES II QP LP; MPM BIOVENTURES II LP; STEINMETZ MICHAEL; MPM ASSET MANAGEMENT II LP; EVNIN LUKE; GALAKATOS NICHOLAS; MPM ASSET MANAGEMENT II LLC; GADICKE ANSBERT; MPM BIOVENTURES GMBH & CO PARALLEL BETEILIGUNGS KG","owner_display_name":"MPM ASSET MANAGEMENT INVESTORS 2001 LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46600.0,"shares_display":"46,600","price_per_share":10.97,"price_display":"10.97","price_state":"stated","total_value":511202.0,"total_display":"511,202.00","total_whole":"511,202","shares_owned_after":1985875.0,"shares_owned_after_display":"1,985,875","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-06-28","filed_date":"2010-06-29","scope":"insider"},{"id":7271401,"accession":"0001209191-10-035959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-035959","line_url":"/filing/0001209191-10-035959#line-1","is_derivative":false,"issuer_cik":"0001097136","issuer_name":"SENORX INC","issuer_ticker":"SENO","issuer_name_source":null,"issuer_url":"/issuer/0001097136","owner_cik":null,"owner_name":"MPM ASSET MANAGEMENT INVESTORS 2001 LLC; MPM BIOVENTURES II QP LP; MPM BIOVENTURES II LP; STEINMETZ MICHAEL; MPM ASSET MANAGEMENT II LP; EVNIN LUKE; GALAKATOS NICHOLAS; MPM ASSET MANAGEMENT II LLC; GADICKE ANSBERT; MPM BIOVENTURES GMBH & CO PARALLEL BETEILIGUNGS KG","owner_display_name":"MPM ASSET MANAGEMENT INVESTORS 2001 LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":161293.0,"shares_display":"161,293","price_per_share":10.97,"price_display":"10.97","price_state":"stated","total_value":1769384.21,"total_display":"1,769,384.21","total_whole":"1,769,384","shares_owned_after":2032475.0,"shares_owned_after_display":"2,032,475","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-06-25","filed_date":"2010-06-29","scope":"insider"},{"id":7609858,"accession":"0001209191-10-023993","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-023993","line_url":"/filing/0001209191-10-023993#line-2","is_derivative":false,"issuer_cik":"0001097136","issuer_name":"SENORX INC","issuer_ticker":"SENO","issuer_name_source":null,"issuer_url":"/issuer/0001097136","owner_cik":null,"owner_name":"MPM ASSET MANAGEMENT II LP; MPM BIOVENTURES GMBH & CO PARALLEL BETEILIGUNGS KG; MPM BIOVENTURES II LP; STEINMETZ MICHAEL; GALAKATOS NICHOLAS; EVNIN LUKE; MPM ASSET MANAGEMENT II LLC; MPM BIOVENTURES II QP LP; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS 2001 LLC","owner_display_name":"MPM ASSET MANAGEMENT II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13900.0,"shares_display":"13,900","price_per_share":10.09,"price_display":"10.09","price_state":"stated","total_value":140251.0,"total_display":"140,251.00","total_whole":"140,251","shares_owned_after":2193768.0,"shares_owned_after_display":"2,193,768","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-04-27","filed_date":"2010-04-28","scope":"insider"},{"id":7609856,"accession":"0001209191-10-023993","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-023993","line_url":"/filing/0001209191-10-023993#line-1","is_derivative":false,"issuer_cik":"0001097136","issuer_name":"SENORX INC","issuer_ticker":"SENO","issuer_name_source":null,"issuer_url":"/issuer/0001097136","owner_cik":null,"owner_name":"MPM ASSET MANAGEMENT II LP; MPM BIOVENTURES GMBH & CO PARALLEL BETEILIGUNGS KG; MPM BIOVENTURES II LP; STEINMETZ MICHAEL; GALAKATOS NICHOLAS; EVNIN LUKE; MPM ASSET MANAGEMENT II LLC; MPM BIOVENTURES II QP LP; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS 2001 LLC","owner_display_name":"MPM ASSET MANAGEMENT II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":10.05,"price_display":"10.05","price_state":"stated","total_value":10050.0,"total_display":"10,050.00","total_whole":"10,050","shares_owned_after":2207668.0,"shares_owned_after_display":"2,207,668","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-04-26","filed_date":"2010-04-28","scope":"insider"},{"id":7530598,"accession":"0001209191-10-023680","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-023680","line_url":"/filing/0001209191-10-023680#line-2","is_derivative":false,"issuer_cik":"0001097136","issuer_name":"SENORX INC","issuer_ticker":"SENO","issuer_name_source":null,"issuer_url":"/issuer/0001097136","owner_cik":null,"owner_name":"MPM BIOVENTURES II LP; STEINMETZ MICHAEL; MPM BIOVENTURES II QP LP; MPM ASSET MANAGEMENT INVESTORS 2001 LLC; MPM ASSET MANAGEMENT II LP; MPM ASSET MANAGEMENT II LLC; EVNIN LUKE; MPM BIOVENTURES GMBH & CO PARALLEL BETEILIGUNGS KG; GADICKE ANSBERT; GALAKATOS NICHOLAS","owner_display_name":"MPM BIOVENTURES II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":10.07,"price_display":"10.07","price_state":"stated","total_value":19133.0,"total_display":"19,133.00","total_whole":"19,133","shares_owned_after":2208668.0,"shares_owned_after_display":"2,208,668","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-04-23","filed_date":"2010-04-26","scope":"insider"},{"id":7530596,"accession":"0001209191-10-023680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-023680","line_url":"/filing/0001209191-10-023680#line-1","is_derivative":false,"issuer_cik":"0001097136","issuer_name":"SENORX INC","issuer_ticker":"SENO","issuer_name_source":null,"issuer_url":"/issuer/0001097136","owner_cik":null,"owner_name":"MPM BIOVENTURES II LP; STEINMETZ MICHAEL; MPM BIOVENTURES II QP LP; MPM ASSET MANAGEMENT INVESTORS 2001 LLC; MPM ASSET MANAGEMENT II LP; MPM ASSET MANAGEMENT II LLC; EVNIN LUKE; MPM BIOVENTURES GMBH & CO PARALLEL BETEILIGUNGS KG; GADICKE ANSBERT; GALAKATOS NICHOLAS","owner_display_name":"MPM BIOVENTURES II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31811.0,"shares_display":"31,811","price_per_share":10.06,"price_display":"10.06","price_state":"stated","total_value":320018.66,"total_display":"320,018.66","total_whole":"320,019","shares_owned_after":2210568.0,"shares_owned_after_display":"2,210,568","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-04-22","filed_date":"2010-04-26","scope":"insider"},{"id":1532635,"accession":"0001209191-05-033131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-05-033131","line_url":"/filing/0001209191-05-033131#line-1","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"GADICKE ANSBERT; MPM BIOVENTURES II LP; STEINMETZ MICHAEL; WHEELER KURT; MPM BIOVENTURES II GMBH & CO PARALLEL BETEILIGUNGS KG; MPM ASSET MANAGEMENT II LP; MPM ASSET MANAGEMENT II LLC; MPM ASSET MANAGEMENT INVESTORS 2001 LLC; MPM BIOVENTURES II QP LP; EVNIN LUKE","owner_display_name":"GADICKE ANSBERT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":547446.0,"shares_display":"547,446","price_per_share":5.48,"price_display":"5.48","price_state":"stated","total_value":3000004.08,"total_display":"3,000,004.08","total_whole":"3,000,004","shares_owned_after":4845877.0,"shares_owned_after_display":"4,845,877","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-06-20","filed_date":"2005-06-22","scope":"insider"},{"id":9260068,"accession":"0001209191-05-038552","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-05-038552","line_url":"/filing/0001209191-05-038552#line-1","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; MPM ASSET MANAGEMENT II LLC; MPM ASSET MANAGEMENT II LP; MPM ASSET MANAGEMENT INVESTORS 2001 LLC; MPM BIOVENTURES II GMBH & CO PARALLEL BETEILIGUNGS KG; MPM BIOVENTURES II LP; MPM BIOVENTURES II QP LP; STEINMETZ MICHAEL; WHEELER KURT","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":357100.0,"shares_display":"357,100","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2499700.0,"total_display":"2,499,700.00","total_whole":"2,499,700","shares_owned_after":4298430.0,"shares_owned_after_display":"4,298,430","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-06-02","filed_date":"2005-07-26","scope":"insider"},{"id":9259809,"accession":"0001209191-05-022617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-05-022617","line_url":"/filing/0001209191-05-022617#line-1","is_derivative":false,"issuer_cik":"0001249133","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001249133","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS 2001 LLC; MPM BIOVENTURES III GMBH & CO; MPM BIOVENTURES III GP LP; MPM BIOVENTURES III LLC; MPM BIOVENTURES III LP; MPM BIOVENTURES III QP LP; STEINMETZ MICHAEL; WHEELER KURT","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":357100.0,"shares_display":"357,100","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2499700.0,"total_display":"2,499,700.00","total_whole":"2,499,700","shares_owned_after":4298430.0,"shares_owned_after_display":"4,298,430","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-06-02","filed_date":"2005-04-28","scope":"insider"},{"id":633156,"accession":"0001209191-04-029168","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-04-029168","line_url":"/filing/0001209191-04-029168#line-3","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"MPM BIOVENTURES III GP LP; MPM BIOVENTURES III GMBH & CO; MPM BIOVENTURES III QP LP; MPM ASSET MANAGEMENT INVESTORS 2001 LLC; GADICKE ANSBERT; EVNIN LUKE; WHEELER KURT; STEINMETZ MICHAEL; MPM BIOVENTURES III LLC; MPM BIOVENTURES III LP","owner_display_name":"MPM BIOVENTURES III GP LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":357100.0,"shares_display":"357,100","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2499700.0,"total_display":"2,499,700.00","total_whole":"2,499,700","shares_owned_after":4298430.0,"shares_owned_after_display":"4,298,430","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-06-02","filed_date":"2004-06-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001097136","name":"SENORX INC","url":"/issuer/0001097136","role":"Ten percent owner","n_filings":3,"first_seen":"2010-04-26","last_seen":"2010-06-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001145404","name":"CRITICAL THERAPEUTICS INC","url":"/issuer/0001145404","role":"Ten percent owner","n_filings":4,"first_seen":"2004-06-02","last_seen":"2005-07-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001264824","retrieved_at":"2026-08-23T13:32:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}